Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2536 entries
Sorted by: Best Match Show Resources per page
Molecular Action and Clinical Relevance of Aromatase Inhibitors.

The oncologist

Murphy MJ.
PMID: 10388095
Oncologist. 1998;3(2):129-130.

BREAST CANCER: HIGH PREVALENCE AND RISING INCIDENCE: Breast cancer is the most common form of cancer among women in Europe, North and South America and Australasia; approximately 1 in 10 women in Western countries will develop breast cancer during...

Cite
Murphy MJ. Molecular Action and Clinical Relevance of Aromatase Inhibitors. Oncologist. 1998;3(2):129-130
Murphy, M. J. (1998). Molecular Action and Clinical Relevance of Aromatase Inhibitors. The oncologist, 3(2), 129-130.
Murphy. "Molecular Action and Clinical Relevance of Aromatase Inhibitors." The oncologist vol. 3,2 (1998): 129-130.
Murphy MJ. Molecular Action and Clinical Relevance of Aromatase Inhibitors. Oncologist. 1998;3(2):129-130. PMID: 10388095.
Copy Download .nbib Format: NLM
Prevalence and Management of Diabetic Nephropathy in Western Countries.

Kidney diseases (Basel, Switzerland)

Satirapoj B, Adler SG.
PMID: 27536666
Kidney Dis (Basel). 2015 May;1(1):61-70. doi: 10.1159/000382028. Epub 2015 May 01.

BACKGROUND: Diabetic nephropathy (DN) often results in end-stage renal disease, and this is the most common reason for initiation of dialysis in the United States. Complications of diabetes, particularly renal disease, substantially increase the risk of subsequent severe illness...

Cite
Satirapoj B, Adler SG. Prevalence and Management of Diabetic Nephropathy in Western Countries. Kidney Dis (Basel). 2015;1(1):61-70doi: 10.1159/000382028.
Satirapoj, B., & Adler, S. G. (2015). Prevalence and Management of Diabetic Nephropathy in Western Countries. Kidney diseases (Basel, Switzerland), 1(1), 61-70. https://doi.org/10.1159/000382028
Satirapoj, Bancha, and Adler, Sharon G. "Prevalence and Management of Diabetic Nephropathy in Western Countries." Kidney diseases (Basel, Switzerland) vol. 1,1 (2015): 61-70. doi: https://doi.org/10.1159/000382028
Satirapoj B, Adler SG. Prevalence and Management of Diabetic Nephropathy in Western Countries. Kidney Dis (Basel). 2015 May;1(1):61-70. doi: 10.1159/000382028. Epub 2015 May 01. PMID: 27536666; PMCID: PMC4934803.
Copy Download .nbib Format: NLM
Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension.

American journal of obstetrics and gynecology

Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA.
PMID: 32828743
Am J Obstet Gynecol. 2020 Aug 20; doi: 10.1016/j.ajog.2020.08.018. Epub 2020 Aug 20.

OBJECTIVE: This study aimed to review pregnancy hypertension clinical practice guidelines to inform international clinical practice and research priorities.STUDY ELIGIBILITY CRITERIA: Relevant national and international clinical practice guidelines, 2009-19, published in English, French, Dutch or German.STUDY APPRAISAL AND SYNTHESIS...

Cite
Scott G, Gillon TE, Pels A, et al. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2020;doi: 10.1016/j.ajog.2020.08.018.
Scott, G., Gillon, T. E., Pels, A., von Dadelszen, P., & Magee, L. A. (2020). Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2020.08.018
Scott, Georgia, et al. "Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension." American journal of obstetrics and gynecology vol. (2020). doi: https://doi.org/10.1016/j.ajog.2020.08.018
Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2020 Aug 20; doi: 10.1016/j.ajog.2020.08.018. Epub 2020 Aug 20. PMID: 32828743.
Copy Download .nbib Format: NLM
Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.

Journal of managed care & specialty pharmacy

Polson M, Lord TC, Kangethe A, Speicher L, Farnum C, Brenner M, Oestreicher N, Alvarez P.
PMID: 28485202
J Manag Care Spec Pharm. 2017 Apr;23(4):S2-S9. doi: 10.18553/jmcp.2017.23.4-a.s2a.

BACKGROUND: Hyperkalemia (HK) is a concern for patients with chronic kidney disease (CKD) and heart failure (HF), and for those receiving treatments that inhibit the renin-angiotensin-aldosterone system (RAASi). An analysis of 1.7 million medical records of patients in the...

Cite
Polson M, Lord TC, Kangethe A, et al. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure. J Manag Care Spec Pharm. 2017;23(4):S2-S9doi: 10.18553/jmcp.2017.23.4-a.s2a.
Polson, M., Lord, T. C., Kangethe, A., Speicher, L., Farnum, C., Brenner, M., Oestreicher, N., & Alvarez, P. (2017). Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure. Journal of managed care & specialty pharmacy, 23(4), S2-S9. https://doi.org/10.18553/jmcp.2017.23.4-a.s2a
Polson, Michael, et al. "Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure." Journal of managed care & specialty pharmacy vol. 23,4 (2017): S2-S9. doi: https://doi.org/10.18553/jmcp.2017.23.4-a.s2a
Polson M, Lord TC, Kangethe A, Speicher L, Farnum C, Brenner M, Oestreicher N, Alvarez P. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure. J Manag Care Spec Pharm. 2017 Apr;23(4):S2-S9. doi: 10.18553/jmcp.2017.23.4-a.s2a. PMID: 28485202.
Copy Download .nbib Format: NLM
Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study.

Current therapeutic research, clinical and experimental

Lin MS, Chan KA, Wang CH, Chang NC.
PMID: 24936117
Curr Ther Res Clin Exp. 2004 Mar;65(2):204-21. doi: 10.1016/S0011-393X(04)90034-3.

BACKGROUND: Two second-generation calcium channel blockers, felodipine and amlodipine besylate, have been associated with similar high mortality rates in patients with ischemic heart failure (HF) but not in patients with nonischemic causes of HF. In patients with nonischemic HF,...

Cite
Lin MS, Chan KA, Wang CH, et al. Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study. Curr Ther Res Clin Exp. 2004;65(2):204-21doi: 10.1016/S0011-393X(04)90034-3.
Lin, M. S., Chan, K. A., Wang, C. H., & Chang, N. C. (2004). Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study. Current therapeutic research, clinical and experimental, 65(2), 204-21. https://doi.org/10.1016/S0011-393X(04)90034-3
Lin, Mei-Shu, et al. "Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study." Current therapeutic research, clinical and experimental vol. 65,2 (2004): 204-21. doi: https://doi.org/10.1016/S0011-393X(04)90034-3
Lin MS, Chan KA, Wang CH, Chang NC. Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study. Curr Ther Res Clin Exp. 2004 Mar;65(2):204-21. doi: 10.1016/S0011-393X(04)90034-3. PMID: 24936117; PMCID: PMC4052972.
Copy Download .nbib Format: NLM
Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.

JAMA cardiology

Segar MW, Patel RB, Patel KV, Fudim M, DeVore AD, Martens P, Hedayati SS, Grodin JL, Tang WHW, Pandey A.
PMID: 33206129
JAMA Cardiol. 2021 Jan 01;6(1):68-77. doi: 10.1001/jamacardio.2020.5592.

IMPORTANCE: Although kidney dysfunction and abnormalities in serum electrolyte levels are associated with poor clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF), the association of visit-to-visit variability in such laboratory measures with long-term outcomes is...

Cite
Segar MW, Patel RB, Patel KV, et al. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021;6(1):68-77doi: 10.1001/jamacardio.2020.5592.
Segar, M. W., Patel, R. B., Patel, K. V., Fudim, M., DeVore, A. D., Martens, P., Hedayati, S. S., Grodin, J. L., Tang, W. H. W., & Pandey, A. (2021). Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. JAMA cardiology, 6(1), 68-77. https://doi.org/10.1001/jamacardio.2020.5592
Segar, Matthew W, et al. "Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction." JAMA cardiology vol. 6,1 (2021): 68-77. doi: https://doi.org/10.1001/jamacardio.2020.5592
Segar MW, Patel RB, Patel KV, Fudim M, DeVore AD, Martens P, Hedayati SS, Grodin JL, Tang WHW, Pandey A. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021 Jan 01;6(1):68-77. doi: 10.1001/jamacardio.2020.5592. PMID: 33206129; PMCID: PMC7675220.
Copy Download .nbib Format: NLM
Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study.

Hormone molecular biology and clinical investigation

Gocan AG, Bachg D, Schindler AE, Rohr UD.
PMID: 25436688
Horm Mol Biol Clin Investig. 2012 Jun;10(3):301-14. doi: 10.1515/hmbci-2011-0135.

UNLABELLED: Abstract Introduction: A clinical study was conducted to determine steroidal hormone cascade in the blood to relate them to mental performance with the Clinician-Administered PTSD scale (CAPS), serum lipid concentrations, and steroidal hormones, particularly cortisol, testosterone, estradiol, dehydroepiandrosterone...

Cite
Gocan AG, Bachg D, Schindler AE, et al. Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study. Horm Mol Biol Clin Investig. 2012;10(3):301-14doi: 10.1515/hmbci-2011-0135.
Gocan, A. G., Bachg, D., Schindler, A. E., & Rohr, U. D. (2012). Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study. Hormone molecular biology and clinical investigation, 10(3), 301-14. https://doi.org/10.1515/hmbci-2011-0135
Gocan, Anca G, et al. "Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study." Hormone molecular biology and clinical investigation vol. 10,3 (2012): 301-14. doi: https://doi.org/10.1515/hmbci-2011-0135
Gocan AG, Bachg D, Schindler AE, Rohr UD. Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study. Horm Mol Biol Clin Investig. 2012 Jun;10(3):301-14. doi: 10.1515/hmbci-2011-0135. PMID: 25436688.
Copy Download .nbib Format: NLM
Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.

JAMA cardiology

Segar MW, Patel RB, Patel KV, Fudim M, DeVore AD, Martens P, Hedayati SS, Grodin JL, Tang WHW, Pandey A.
PMID: 33206129
JAMA Cardiol. 2021 Jan 01;6(1):68-77. doi: 10.1001/jamacardio.2020.5592.

IMPORTANCE: Although kidney dysfunction and abnormalities in serum electrolyte levels are associated with poor clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF), the association of visit-to-visit variability in such laboratory measures with long-term outcomes is...

Cite
Segar MW, Patel RB, Patel KV, et al. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021;6(1):68-77doi: 10.1001/jamacardio.2020.5592.
Segar, M. W., Patel, R. B., Patel, K. V., Fudim, M., DeVore, A. D., Martens, P., Hedayati, S. S., Grodin, J. L., Tang, W. H. W., & Pandey, A. (2021). Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. JAMA cardiology, 6(1), 68-77. https://doi.org/10.1001/jamacardio.2020.5592
Segar, Matthew W, et al. "Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction." JAMA cardiology vol. 6,1 (2021): 68-77. doi: https://doi.org/10.1001/jamacardio.2020.5592
Segar MW, Patel RB, Patel KV, Fudim M, DeVore AD, Martens P, Hedayati SS, Grodin JL, Tang WHW, Pandey A. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021 Jan 01;6(1):68-77. doi: 10.1001/jamacardio.2020.5592. PMID: 33206129; PMCID: PMC7675220.
Copy Download .nbib Format: NLM
Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study.

JMIR medical informatics

Wu CW, Chen HY, Yang CW, Chen YC.
PMID: 33973855
JMIR Med Inform. 2021 May 11;9(5):e27614. doi: 10.2196/27614.

BACKGROUND: Diabetic kidney disease (DKD) is one of the most crucial causes of chronic kidney disease (CKD). However, the efficacy and biomedical mechanisms of Chinese herbal medicine (CHM) for DKD in clinical settings remain unclear.OBJECTIVE: This study aimed to...

Cite
Wu CW, Chen HY, Yang CW, et al. Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study. JMIR Med Inform. 2021;9(5):e27614doi: 10.2196/27614.
Wu, C. W., Chen, H. Y., Yang, C. W., & Chen, Y. C. (2021). Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study. JMIR medical informatics, 9(5), e27614. https://doi.org/10.2196/27614
Wu, Chien-Wei, et al. "Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study." JMIR medical informatics vol. 9,5 (2021): e27614. doi: https://doi.org/10.2196/27614
Wu CW, Chen HY, Yang CW, Chen YC. Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study. JMIR Med Inform. 2021 May 11;9(5):e27614. doi: 10.2196/27614. PMID: 33973855; PMCID: PMC8150407.
Copy Download .nbib Format: NLM
External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery.

JAMA network open

Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima KI, Akai Y, Tsuruya K.
PMID: 34661665
JAMA Netw Open. 2021 Oct 01;4(10):e2127362. doi: 10.1001/jamanetworkopen.2021.27362.

IMPORTANCE: The Simple Postoperative AKI Risk (SPARK) index is a prediction model for postoperative acute kidney injury (PO-AKI) in patients undergoing noncardiac surgery. External validation has not been performed.OBJECTIVE: To externally validate the SPARK index.DESIGN, SETTING, AND PARTICIPANTS: This...

Cite
Nishimoto M, Murashima M, Kokubu M, et al. External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery. JAMA Netw Open. 2021;4(10):e2127362doi: 10.1001/jamanetworkopen.2021.27362.
Nishimoto, M., Murashima, M., Kokubu, M., Matsui, M., Eriguchi, M., Samejima, K. I., Akai, Y., & Tsuruya, K. (2021). External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery. JAMA network open, 4(10), e2127362. https://doi.org/10.1001/jamanetworkopen.2021.27362
Nishimoto, Masatoshi, et al. "External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery." JAMA network open vol. 4,10 (2021): e2127362. doi: https://doi.org/10.1001/jamanetworkopen.2021.27362
Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima KI, Akai Y, Tsuruya K. External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery. JAMA Netw Open. 2021 Oct 01;4(10):e2127362. doi: 10.1001/jamanetworkopen.2021.27362. PMID: 34661665; PMCID: PMC8524308.
Copy Download .nbib Format: NLM
External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery.

JAMA network open

Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima KI, Akai Y, Tsuruya K.
PMID: 34661665
JAMA Netw Open. 2021 Oct 01;4(10):e2127362. doi: 10.1001/jamanetworkopen.2021.27362.

IMPORTANCE: The Simple Postoperative AKI Risk (SPARK) index is a prediction model for postoperative acute kidney injury (PO-AKI) in patients undergoing noncardiac surgery. External validation has not been performed.OBJECTIVE: To externally validate the SPARK index.DESIGN, SETTING, AND PARTICIPANTS: This...

Cite
Nishimoto M, Murashima M, Kokubu M, et al. External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery. JAMA Netw Open. 2021;4(10):e2127362doi: 10.1001/jamanetworkopen.2021.27362.
Nishimoto, M., Murashima, M., Kokubu, M., Matsui, M., Eriguchi, M., Samejima, K. I., Akai, Y., & Tsuruya, K. (2021). External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery. JAMA network open, 4(10), e2127362. https://doi.org/10.1001/jamanetworkopen.2021.27362
Nishimoto, Masatoshi, et al. "External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery." JAMA network open vol. 4,10 (2021): e2127362. doi: https://doi.org/10.1001/jamanetworkopen.2021.27362
Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima KI, Akai Y, Tsuruya K. External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery. JAMA Netw Open. 2021 Oct 01;4(10):e2127362. doi: 10.1001/jamanetworkopen.2021.27362. PMID: 34661665; PMCID: PMC8524308.
Copy Download .nbib Format: NLM
Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

Myrda K, Rozentryt P, Niedziela JT, Ociessa A, Kasperova M, Hudzik B, Nowak JU, Gąsior M.
PMID: 26702277
Kardiochir Torakochirurgia Pol. 2015 Sep;12(3):216-27. doi: 10.5114/kitp.2015.54457. Epub 2015 Sep 28.

INTRODUCTION: The activation of the renin-angiotensin-aldosterone (RAA) system is a main element of the pathophysiology of chronic heart failure (CHF), determining its symptoms and prognosis. Vitamin D is an RAA inhibitor, and its deficiency frequently accompanies CHF. The factors...

Cite
Myrda K, Rozentryt P, Niedziela JT, et al. Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients. Kardiochir Torakochirurgia Pol. 2015;12(3):216-27doi: 10.5114/kitp.2015.54457.
Myrda, K., Rozentryt, P., Niedziela, J. T., Ociessa, A., Kasperova, M., Hudzik, B., Nowak, J. U., & Gąsior, M. (2015). Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 12(3), 216-27. https://doi.org/10.5114/kitp.2015.54457
Myrda, Krzysztof, et al. "Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients." Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery vol. 12,3 (2015): 216-27. doi: https://doi.org/10.5114/kitp.2015.54457
Myrda K, Rozentryt P, Niedziela JT, Ociessa A, Kasperova M, Hudzik B, Nowak JU, Gąsior M. Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients. Kardiochir Torakochirurgia Pol. 2015 Sep;12(3):216-27. doi: 10.5114/kitp.2015.54457. Epub 2015 Sep 28. PMID: 26702277; PMCID: PMC4631913.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2536 entries